FIELD: pharmaceutical chemistry.
SUBSTANCE: inventions group relates to the field of pharmaceutical chemistry and includes a compound of formula (I) and a pharmaceutical composition based on it, where in formula (I) R1 and R2 are independently C1-3 alkyl; or R1 and R2 are combined to form a 5-7 membered carbocyclic ring, wherein said carbocyclic ring may be saturated or unsaturated; R3 is ; R4 is C1-6 alkyl or (CH2)nO(CH2)mCH3, where C1-6 alkyl or any carbon atom of the (CH2)nO(CH2)mCH3 group is substituted with 0 to 3 halogens, as far as valence permits; R5 is C1-3 alkyl or OC1-3 alkyl, where C1-3 alkyl is substituted with 0 to 3 F; R6 is H or C1-3 alkyl, where C1-3 alkyl is substituted with 0 to 3 F; m is 0-2; n is 1-3.
EFFECT: compound of formula (I) having TLR7/TLR8 agonist activity.
21 cl, 1 tbl, 19 ex
Title | Year | Author | Number |
---|---|---|---|
NEW COMPOUNDS AND THEIR PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF INFLAMMATORY DISEASES | 2018 |
|
RU2785126C2 |
PHARMACEUTICALLY ACTIVE COMPOUNDS | 2013 |
|
RU2654942C2 |
DERIVATIVE OF PYRIMIDINE AND A FIVE-MEMBERED NITROGEN-CONTAINING HETEROCYCLE, METHOD FOR PRODUCTION AND MEDICAL APPLICATIONS THEREOF | 2019 |
|
RU2775229C1 |
PYRAZOLE DERIVATIVE SUITABLE AS PI3K INHIBITOR | 2016 |
|
RU2710549C2 |
CHEMICAL COMPOUNDS-759 | 2008 |
|
RU2481348C2 |
MACROCYCLIC TYROSINE KINASE INHIBITOR AND ITS USE | 2019 |
|
RU2798231C2 |
HETEROARYL COMPOUNDS AS TKB INHIBITORS AND USE THEREOF | 2015 |
|
RU2742122C2 |
4-AMINO-IMIDAZOQUINOLINE DERIVATIVES, USEFUL IN TREATING DISEASES MEDIATED BY TLR7 AND/OR TLR8 AGONISTS | 2015 |
|
RU2698902C2 |
PROTEIN TYROSIN PHOSPHATASE INHIBITORS | 2020 |
|
RU2799449C2 |
TRICYCLIC JANUS KINASE 1 INHIBITORS, COMPOSITIONS, METHODS OF PRODUCTION AND USE THEREOF | 2019 |
|
RU2824349C2 |
Authors
Dates
2022-12-05—Published
2020-07-14—Filed